Home/Biofrontera/George Jones
GJ

George Jones

Chief Commercial Officer

Biofrontera

Therapeutic Areas

Biofrontera Pipeline

DrugIndicationPhase
BF-200 ALA (Ameluz®)Actinic Keratosis - PharmacokineticsN/A (Post-Approval)